Chikhaoui Y, Boussioux AM, Nicolas JC, Descomps B, Crastes de Paulet A. Active site-directed irreversible inhibition of 3 beta-hydroxysteroid dehydrogenase from human placenta.
JOURNAL OF STEROID BIOCHEMISTRY 1983;
19:1213-7. [PMID:
6224979 DOI:
10.1016/0022-4731(83)90419-3]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
To obtain a placental microsome preparation able to convert androstenedione and testosterone specifically to estrogens, 3 beta-hydroxysteroid dehydrogenase must be eliminated. After solubilisation by Triton X-100, the remaining 3 beta-hydroxysteroid dehydrogenase activity is inhibited by 11 alpha-bromoacetoxyprogesterone, an alkylating analogue of progesterone, which behaves as an irreversible active site-directed inhibitor. The enzyme is protected against inactivation and alkylation by steroid and coenzyme substrates. The inhibition is specific to 3 beta-hydroxysteroid dehydrogenase and the estrogen synthetase (aromatase) activity contained in the preparation is not affected by this inhibitor.
Collapse